Drugs / PG101
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02078661 Comparator | Dec 2013 → Jan 2014 | dry eye syndrome | Rhodes Pharmaceuticals, L.P. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PG101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02078661 ↗ |